Table:
begin	end	state
1	11	non-cytoplasmic
12	37	transmembrane
38	40	cytoplasmic
41	71	transmembrane
72	105	non-cytoplasmic
106	133	transmembrane
134	142	cytoplasmic
143	161	transmembrane
162	166	non-cytoplasmic
167	186	transmembrane
187	197	cytoplasmic
198	221	transmembrane
222	255	non-cytoplasmic
256	279	transmembrane
280	313	cytoplasmic
314	337	transmembrane
338	354	non-cytoplasmic
355	377	transmembrane
378	388	cytoplasmic
389	405	transmembrane
406	410	non-cytoplasmic
411	426	transmembrane
427	429	non-cytoplasmic
430	432	cytoplasmic
433	451	transmembrane
452	467	non-cytoplasmic
468	488	transmembrane
489	498	cytoplasmic

Input:
>HSERO_RS16690
MFANIYAAFGMVFDPYVLAVILGSSIFGLFMGAVPGLSATMAVALLVPVTFFMPPVPAIA
AMVSATAMAIFSGDIPGCLLRIPGTPSSAAYTDEAYAMTMKGQGEIALGASLVFSVIGGL
FGTFVLILAAPALAELALKFSSFEYFWLVLLGLTCAIFIASDNPLKGFVSLFLGMFIASI
GMGNPAGAPRFTFDQPDLLGGVSLVPLMVGMFAMSEVLRFAVSRDFSMKVAESRVGNVFK
GMWGLMIKYPKSVLRGSVLGTLVGALPGAGADIAAWMSYAMSKKLSKEPEKFGTGHPEGI
VESGAANNSALAGAWIPALVFGIPGDSITAIVIGVLYMKNLNPGPMIFVENPVSMYAIFI
VFILANLLMLPLGFWCIKMAKRILSIPRGILMPLILLFCIVGSYATNNSVTDVGIMLVFG
LLAYVMEENGFPVAPAVLGVVLGGMLEEHFVTSMIKADGQFLAFFERPIAGTLGVITLLL
WLLPLALKLVRRKTLATA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server